Macrogenics (NASDAQ: MGNX) reported Q2 EPS of $0.92, $1.44 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $29.19 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.